Clinical features and mutation analysis of X-linked agammaglobulinemia in 20 Chinese patients

World Journal of Pediatrics

Volumn 9, Issue 3, 2013, Pages 273-277

  Qin, Xian ^a,b,c,d   Jiang, Li Ping ^a,b,c,d   Tang, Xue Mei ^a,b,c,d   Wang, Mo ^a,b,c,d   Liu, En Mei ^a,b,c,d   Zhao, Xiao Dong ^a,b,c,d,e  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Key Laboratory of Pediatrics   (China)

^d Chongqing Intl Science and Technology Cooperation Center for Child Development and Disorders   (China)

^e CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

BTK gene; genotype phenotype correlation; mutations; X linked agammaglobulinemia

Indexed keywords

BRUTON TYROSINE KINASE;

ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; GENE AMPLIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HUMAN; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PRESCHOOL CHILD; RNA SPLICING; SCHOOL CHILD; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MUTATION, MISSENSE;

EID: 84882284662     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-013-0400-x     Document Type: Article

References (20)

1. Bruton OC. Agammaglobulinemia. Pediatrics 1952;9:722-728.
2. Nomura K, Kanegane H, Karasuyama H, Tsukada S, Agematsu K, Murakami G, et al. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway. Blood 2000;96:610-617.
3. Vetrie D, Vorechovský I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993;361:226-233.
4. Wang XC, Wang Y, Kanegane H, Toshio M, Yu YH. Gene diagnosis of X-linked agammaglobulinemia. Zhonghua Er Ke Za Zhi 2005;43:449-452.
5. Lee PP, Chen TX, Jiang LP, Chan KW, Yang W, Lee BW, et al. Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. J Clin Immunol 2010;30:121-131.
6. Wang Y, Kanegane H, Wang X, Han X, Zhang Q, Zhao S, et al. Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China. J Clin Immunol 2009;29:352-356.
7. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190-197.
8. Brooimans RA, van den Berg AJ, Rijkers GT, Sanders LA, van Amstel JK, Tilanus MG, et al. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. J Med Genet 1997;34:484-848.
9. Vorechovský I, Vihinen M, de Saint Basile G, Honsová S, Hammarström L, Müller S, et al. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia. Hum Mol Genet 1995;4:51-58.
10. Ochs HD, Notarangelo LD. X-linked immunodeficiencies. Curr Allergy Asthma Rep 2004;4:339-348.
11. Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr 2002;141:566-571.
12. Stewart DM, Lian L, Nelson DL. The clinical spectrum of Bruton's agammaglobulinemia. Curr Allergy Asthma Rep 2001;1:558-565.
13. Zhang ZY, Zhao XD, Jiang LP, Liu EM, Wang M, Yu J, et al. Clinical characteristics and molecular analysis of 21 Chinese children with congenital agammaglobulinemia. Scand J Immunol 2010;72:454-459.
14. Conley ME, Mathias D, Treadaway J, Minegishi Y, Rohrer J. Mutations in btk in patients with presumed X-linked agammaglobulinemia. Am J Hum Genet 1998;62:1034-1043.
15. Wicker LS, Scher I. X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol 1986;124:87-101.
16. Rawlings DJ, Witte ON. Bruton's tyrosine kinase is a key regulator in B-cell development. Immunol Rev 1994;138:105-119.
17. Smith CI, Islam KB, Vorechovský I, Olerup O, Wallin E, Rabbani H, et al. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev 1994;138:159-183.
18. Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, et al. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol 2001;108:1012-1020.
19. Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, et al. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 uniquemutations without correlation to clinical course. Pediatrics 1998;101:276-284.
20. Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev 2005;203:200-215.